论文部分内容阅读
目的:探究黄芪桃红汤联合CEF方案化疗对乳腺癌术后患者免疫功能的影响。方法:选择2013年10月-2016年4月我院收治的乳腺癌术后患者120例,按随机数字表法分为两组,每组60例。对照组实施CEF方案化疗,观察组实施黄芪桃红汤联合CEF方案化疗,比较两组患者治疗前、治疗后9周的机体免疫[免疫球蛋白G(I_gG)、免疫球蛋白M(I_gM)、免疫球蛋白A(I_gA)]功能。结果:治疗前,两组患者I_gG、I_gM、I_gA水平比较,差异无统计学意义(P>0.05);治疗后,观察组I_g G、I_g M、I_g A水平与对照组相比均有提高,差异有统计学意义(P<0.05)。结论:黄芪桃红汤联合CEF方案化疗能有效改善乳腺癌术后患者免疫功能。
Objective: To investigate the effects of Huangqi Taohong Decoction combined with CEF chemotherapy on immune function in postoperative patients with breast cancer. Methods: From October 2013 to April 2016, 120 cases of postoperative patients with breast cancer admitted to our hospital were divided into two groups according to random number table method, 60 cases in each group. The control group was treated with CEF regimen. The observation group was treated with Huangqi Taohong Decoction combined with CEF regimen. The immune responses of the two groups were compared before and 9 weeks after treatment (immunoglobulin G, IgM, I_gM) Globulin A (I_gA)] function. Results: Before treatment, the levels of I_gG, I_gM and I_gA in the two groups had no significant difference (P> 0.05). After treatment, the levels of I_gG, I_g M and I_gA in the observation group were all higher than those in the control group, The difference was statistically significant (P <0.05). Conclusion: Huangqi Taohong Decoction combined with CEF chemotherapy can effectively improve the immune function of postoperative patients with breast cancer.